Revivicor sells regenerative therapy rights
20th Sep 2005, 20:29 GMT
Revivicor Inc., a Virginia company owned by the University of Pittsburgh Medical Center and Highmark Inc., is selling distribution rights to a type of genetically engineered tissue used for regenerative therapies.
Latest news from bizjournals.com Health Care:Biotechnology headlines:
- Baylor researchers make heart disease finding
- ZymoGenetics encouraged by early results on lupus treatment
- ActivBiotics shelves IPO plans
- Delta Search Labs spinoff wins Air Force deal for toxin detector
- UTSA joins regional research university alliance on border security
- Intact Medical launches breast cancer detection device